| Literature DB >> 34183861 |
Luke W Koblan1,2,3, Mandana Arbab1,2,3, Max W Shen1,2,3,4, Jeffrey A Hussmann5,6,7,8,9, Andrew V Anzalone1,2,3, Jordan L Doman1,2,3, Gregory A Newby1,2,3, Dian Yang5,7,8,9, Beverly Mok1,2,3, Joseph M Replogle5,7,10,11,8,9, Albert Xu5,6,10,12, Tyler A Sisley2, Jonathan S Weissman13,14,15,16,17, Britt Adamson18,19,20,21, David R Liu22,23,24.
Abstract
Programmable C•G-to-G•C base editors (CGBEs) have broad scientific and therapeutic potential, but their editing outcomes have proved difficult to predict and their editing efficiency and product purity are often low. We describe a suite of engineered CGBEs paired with machine learning models to enable efficient, high-purity C•G-to-G•C base editing. We performed a CRISPR interference (CRISPRi) screen targeting DNA repair genes to identify factors that affect C•G-to-G•C editing outcomes and used these insights to develop CGBEs with diverse editing profiles. We characterized ten promising CGBEs on a library of 10,638 genomically integrated target sites in mammalian cells and trained machine learning models that accurately predict the purity and yield of editing outcomes (R = 0.90) using these data. These CGBEs enable correction to the wild-type coding sequence of 546 disease-related transversion single-nucleotide variants (SNVs) with >90% precision (mean 96%) and up to 70% efficiency (mean 14%). Computational prediction of optimal CGBE-single-guide RNA pairs enables high-purity transversion base editing at over fourfold more target sites than achieved using any single CGBE variant.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34183861 PMCID: PMC8985520 DOI: 10.1038/s41587-021-00938-z
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908